- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Drone Delivery Canada Announces Closing of Bought Deal Financing for Aggregate Gross Proceeds of $15 Million
Drone Delivery Canada (CSE:FLT”) has announced it has closed its previously announced bought-deal prospectus offering pursuant to which the company issued 23 million common shares at $0.65 per share for aggregate proceeds of $15 million. As quoted in the press release: The Common Shares were offered by way of a short form prospectus filed in …
Drone Delivery Canada (CSE:FLT”) has announced it has closed its previously announced bought-deal prospectus offering pursuant to which the company issued 23 million common shares at $0.65 per share for aggregate proceeds of $15 million.
As quoted in the press release:
The Common Shares were offered by way of a short form prospectus filed in all provinces of Canada. The Company intends to use the net proceeds from the Offering to explore the expansion of its testing and commercialization program into the United States and other international jurisdictions selected by the Company, concurrent with the Company’s continuing activities to advance its testing and commercialization program in Canada.
The securities issued pursuant to the Offering have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.